| Screening for fetal growth restriction and placental insufficiency |
25 |
| A critical analysis of risk factors for necrotizing enterocolitis |
17 |
| Intestinal microcirculation and necrotizing enterocolitis: The vascular endothelial growth factor system |
14 |
| Beyond screening for chromosomal abnormalities: Advances in non-invasive diagnosis of single gene disorders and fetal exome sequencing |
12 |
| Optimizing antenatal corticosteroid therapy |
12 |
| Necrotizing enterocolitis: The intestinal microbiome, metabolome and inflammatory mediators |
12 |
| Epidemiology of late preterm and early term births - An international perspective |
12 |
| Long-term effects of neonatal pain |
11 |
| Innate and adaptive immunity in necrotizing enterocolitis |
10 |
| Genetic predisposition to necrotizing enterocolitis in premature infants: Current knowledge, challenges, and future directions |
10 |
| Outcomes after acute symptomatic seizures in neonates |
10 |
| Ethics and palliative care in the perinatal world |
9 |
| The prediction of preterm delivery: What is new? |
9 |
| Parental experiences after prenatal diagnosis of fetal abnormality |
9 |
| Necrotizing enterocolitis comes in different forms: Historical perspectives and defining the disease |
9 |
| Maintaining normothermia: Why and how? |
9 |
| First and second trimester screening for fetal structural anomalies |
8 |
| Neonatal epilepsy genetics |
8 |
| Neonatal epilepsies: Clinical management |
8 |
| The use and misuse of moral distress in neonatology |
8 |
| The genetics and epigenetics of Neonatal Abstinence Syndrome |
8 |
| Amplitude-integrated electroencephalography for seizure detection in newborn infants |
7 |
| Screening for spontaneous preterm birth and resultant therapies to reduce neonatal morbidity and mortality: A review |
7 |
| Hemodynamic assessment of the patent ductus arteriosus: Beyond ultrasound |
7 |
| Patent ductus arteriosus: The physiology of transition |
6 |
| Role of neonatologist-performed echocardiography in the assessment and management of patent ductus arteriosus physiology in the newborn |
6 |
| Acute symptomatic seizures in term neonates: Etiologies and treatments |
6 |
| Ethical considerations in prenatal testing: Genomic testing and medical uncertainty |
6 |
| Values-based shared decision-making in the antenatal period |
6 |
| The ethics of maternal-fetal surgery |
6 |
| Improving neonatal care with the help of veteran resource parents: An overview of current practices |
6 |
| Neurodevelopmental outcomes of the late preterm infant |
6 |
| Beyond the Finnegan scoring system: Novel assessment and diagnostic techniques for the opioid-exposed infant |
5 |
| Cannabis: An ancient friend or foe? What works and doesn't work |
5 |
| Screening for fetal chromosomal and subchromosomal disorders |
5 |
| Genetic counselling, patient education, and informed decision-making in the genomic era |
5 |
| Non-pharmacological management of a hemodynamically significant patent ductus arteriosus |
5 |
| The science of steroids |
5 |
| An update on biomarkers of necrotizing enterocolitis |
5 |
| Neurodevelopmental outcomes following necrotizing enterocolitis |
5 |
| A new wrinkle: Umbilical cord management (how, when, who) |
4 |
| Effective ventilation: The most critical intervention for successful delivery room resuscitation |
4 |
| Surgical management of a patent ductus arteriosus: Is this still an option? |
4 |
| Epileptogenesis in neonatal brain |
4 |
| Assessment of pain in newborn infants |
4 |
| Ethical implications of the use of decision aids for antenatal counseling at the limits of gestational viability |
4 |
| Health economic aspects of late preterm and early term birth |
4 |
| Early childhood health and morbidity, including respiratory function in late preterm and early term births |
4 |
| Adult outcomes of being born late preterm or early term - What do we know? |
4 |
| Non-pharmacological pain management in the neonatal intensive care unit: Managing neonatal pain without drugs |
3 |
